Circle Brings Native USDC to Injective With Cross-Chain Transfer Protocol

Timothy Morano Mar 17, 2026 13:26

USDC and Circle's CCTP launching on Injective blockchain enables seamless cross-chain transfers and institutional-grade settlement for DeFi traders.

Circle is bringing native USDC issuance and its Cross-Chain Transfer Protocol (CCTP) to Injective, giving the high-performance Layer-1 blockchain direct access to the largest regulated stablecoin without relying on wrapped assets.

The integration, announced by Circle on March 17, means traders and developers on Injective will be able to move USDC seamlessly between the network and other CCTP-supported chains including Ethereum, Solana, and Cosmos-based protocols. Testnet is live now, with mainnet launch timing still to be announced.

Why This Matters for Injective

Injective isn't your typical smart contract platform. The network embeds financial primitives directly at the protocol layer—including a decentralized central limit order book, derivatives infrastructure, and RWA support. Think of it as DeFi rails built for institutions rather than bolted on afterward.

The chain already processes over 10,000 TPS with sub-second finality and transaction fees that typically run under a cent. Native USDC adds the missing piece: a regulated, dollar-denominated settlement asset that doesn't require trust assumptions from bridge operators.

Recent ecosystem activity suggests timing could be favorable. Social discussions around INJ spiked up to 80% in mid-March alongside other RWA-focused tokens, according to market data from March 14. KuCoin also completed support for an Injective network upgrade on March 9, ensuring exchange infrastructure stays current.

What CCTP Actually Does

Circle's CCTP eliminates the wrapped token problem that plagues cross-chain liquidity. When you bridge USDC via CCTP, Circle burns tokens on the source chain and mints fresh ones on the destination. No intermediary custody, no wrapped asset risk.

For Injective's target users—institutional traders, market makers, and increasingly AI-powered trading agents—this matters. Moving collateral between chains to capture arbitrage or rebalance positions becomes a native operation rather than a trust exercise with third-party bridges.

The protocol supports cross-chain onboarding directly into Injective's order book markets, lending protocols, and structured products. Capital efficiency improves when liquidity isn't fragmented across incompatible wrapped versions of the same asset.

Technical Details

The testnet USDC contract is already deployed at 0x0C382e685bbeeFE5d3d9C29e29E341fEE8E84C5d on Injective's testnet. Developers can grab test tokens from Circle's faucet to start building.

Injective's MultiVM environment supports both EVM and CosmWasm smart contracts, so existing Ethereum-native applications can port over while Cosmos developers build natively. The recent native EVM launch further reduces friction for teams migrating from other chains.

What to Watch

Mainnet launch date remains unannounced. Circle typically provides several weeks notice before going live, so expect more details in the coming weeks.

The integration positions Injective as one of the few Cosmos-based chains with direct Circle USDC issuance rather than Noble-bridged versions. For institutions requiring regulatory clarity on their stablecoin exposure, that distinction carries weight.

• usdc
• injective
• cctp
• defi
• stablecoins